BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 30246326)

  • 1. Maternal hemodynamics in screen-positive and screen-negative women of the ASPRE trial.
    Ling HZ; Guy GP; Bisquera A; Poon LC; Nicolaides KH; Kametas NA
    Ultrasound Obstet Gynecol; 2019 Jul; 54(1):51-57. PubMed ID: 30246326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE.
    Tan MY; Poon LC; Rolnik DL; Syngelaki A; de Paco Matallana C; Akolekar R; Cicero S; Janga D; Singh M; Molina FS; Persico N; Jani JC; Plasencia W; Greco E; Papaioannou G; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Jul; 52(1):52-59. PubMed ID: 29704277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal maternal hemodynamics in pregnancies affected by fetal growth restriction.
    Stott D; Papastefanou I; Paraschiv D; Clark K; Kametas NA
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):761-768. PubMed ID: 27854379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental function and fetal weight are associated with maternal hemodynamic indices in uncomplicated pregnancies at 35-37 weeks of gestation.
    Garcia-Gonzalez C; Abdel-Azim S; Galeva S; Georgiopoulos G; Nicolaides KH; Charakida M
    Am J Obstet Gynecol; 2020 Jun; 222(6):604.e1-604.e10. PubMed ID: 31954157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal hemodynamics, fetal biometry and Doppler indices in pregnancies followed up for suspected fetal growth restriction.
    Roberts LA; Ling HZ; Poon LC; Nicolaides KH; Kametas NA
    Ultrasound Obstet Gynecol; 2018 Oct; 52(4):507-514. PubMed ID: 29607557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of impaired placentation at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Ciobanou A; Jabak S; De Castro H; Frei L; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Jul; 54(1):79-86. PubMed ID: 31100188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.
    Tan MY; Syngelaki A; Poon LC; Rolnik DL; O'Gorman N; Delgado JL; Akolekar R; Konstantinidou L; Tsavdaridou M; Galeva S; Ajdacka U; Molina FS; Persico N; Jani JC; Plasencia W; Greco E; Papaioannou G; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Aug; 52(2):186-195. PubMed ID: 29896812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired placentation in women with chronic hypertension who develop pre-eclampsia.
    Panaitescu AM; Akolekar R; Kametas N; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Oct; 50(4):496-500. PubMed ID: 28470791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are maternal hemodynamic indices markers of fetal growth restriction in pregnancies with a small-for-gestational-age fetus?
    Perry H; Lehmann H; Mantovani E; Thilaganathan B; Khalil A
    Ultrasound Obstet Gynecol; 2020 Feb; 55(2):210-216. PubMed ID: 31381215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between central and uterine hemodynamics in hypertensive disorders of pregnancy.
    Perry H; Lehmann H; Mantovani E; Thilaganathan B; Khalil A
    Ultrasound Obstet Gynecol; 2019 Jul; 54(1):58-63. PubMed ID: 30084237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASPRE trial: performance of screening for preterm pre-eclampsia.
    Rolnik DL; Wright D; Poon LCY; Syngelaki A; O'Gorman N; de Paco Matallana C; Akolekar R; Cicero S; Janga D; Singh M; Molina FS; Persico N; Jani JC; Plasencia W; Papaioannou G; Tenenbaum-Gavish K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Oct; 50(4):492-495. PubMed ID: 28741785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competing-risks model for prediction of small-for-gestational-age neonate from biophysical and biochemical markers at 11-13 weeks' gestation.
    Papastefanou I; Wright D; Syngelaki A; Souretis K; Chrysanthopoulou E; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):52-61. PubMed ID: 33094535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-stage approach for prediction of small-for-gestational-age neonate and adverse perinatal outcome by routine ultrasound examination at 35-37 weeks' gestation.
    Akolekar R; Panaitescu AM; Ciobanu A; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):484-491. PubMed ID: 31271475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ophthalmic artery Doppler at 19-23 weeks' gestation in pregnancies that deliver small-for-gestational-age neonates.
    Abdel Azim S; Wright A; Sapantzoglou I; Nicolaides KH; Charakida M
    Ultrasound Obstet Gynecol; 2022 Jul; 60(1):52-58. PubMed ID: 35441758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of first-trimester screening strategy for preterm pre-eclampsia and its clinical applicability in China.
    Hu J; Gao J; Liu J; Meng H; Hao N; Song Y; Ma L; Luo W; Sun J; Gao W; Meng W; Sun Y
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):529-539. PubMed ID: 33817865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.
    O'Gorman N; Wright D; Syngelaki A; Akolekar R; Wright A; Poon LC; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jan; 214(1):103.e1-103.e12. PubMed ID: 26297382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biophysical and biochemical markers at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):203-9. PubMed ID: 26224608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.
    Bakalis S; Peeva G; Gonzalez R; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Oct; 46(4):446-51. PubMed ID: 25826154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.